Malignant neoplasm in kidney transplantation

Area of Science:

• Nephrology
• Oncology
• Immunology

Background:

• Kidney transplant recipients have an elevated cancer risk compared to the general population.
• Cancer incidence in Japan is generally lower than in Western countries.
• The reasons for increased cancer risk in transplant recipients or due to geographical factors are not fully understood.

Purpose of the Study:

• To analyze the incidence and types of malignant neoplasms in kidney transplant recipients.
• To investigate the relationship between immunosuppressive therapy, CD4-positive T lymphocyte counts, and cancer development.
• To determine potential causes or predictors of malignancy in this patient group.

Main Methods:

• Retrospective analysis of 285 kidney transplant recipients followed for 3007 patient-years.
• Examination of the incidence and locations of malignant neoplasms.
• Correlation of immunosuppressive regimens (azathioprine vs. cyclosporine) and CD4 counts with cancer occurrence.

Main Results:

• Six percent of patients (17 of 285) developed 18 malignant neoplasms.
• Cancer incidence reached 13.9% by 20 years post-transplant, with a significant increase in the second decade.
• Digestive organ cancers (liver, colon, rectum, stomach) were most common, mirroring general Japanese cancer patterns; skin cancer and lymphoma were less frequent.
• No direct relationship was found between CD4-positive T lymphocyte counts and malignancy.

Conclusions:

• Malignancy incidence in kidney transplant recipients significantly increases in the second decade after transplantation.
• The distribution of cancer types in kidney transplant recipients resembles that of the general Japanese population.
• This study did not identify the cause or predictive factors for malignancies in kidney transplant patients.